What is NDC 50268-772?

50268-772 is the product NDC for Tranexamic Acid, Tranexamic acid 650 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.

AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tranexamic Acid?

43 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tranexamic Acid NDC 50268-772 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50268-772Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50268-0772Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50268-772-13	5026807721350268077213	30 BLISTER PACK in 1 BOX (50268-772-13) / 1 TABLET in 1 BLISTER PACK (50268-772-11)Marketed from Sep 16, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tranexamic Acid
Generic name (nonproprietary): tranexamic acid
Active ingredients: Tranexamic acid — 650 mg/1
Dosage form: Tablet
Route: Oral
Labeler: AvPAKNDC labeler code 50268
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 022430
Marketing start: Sep 16, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Fibrinolysis (Physiologic effect)
Identifiers: Product ID 50268-772_48364f64-73b3-8c92-e063-6294a90a8b46SPL ID 48364f64-73b3-8c92-e063-6294a90a8b46SPL set ID e8cdb0d6-9498-2902-e053-2995a90a9de4RxCUI 883826UNII 6T84R30KC1
Pharmacologic class: Antifibrinolytic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450268077213 followed by a unit qualifier and the quantity

Package 50268-0772-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 12, 2026.

Indications (excerpt from the label)

Tranexamic acid USP tablets are indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential [see Clinical Studies (14) ]. Tranexamic acid USP tablets is an antifibrinolytic indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50268-772

What is NDC 50268-772?: 50268-772 is the product NDC for Tranexamic Acid, Tranexamic acid 650 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tranexamic Acid.
What is the active ingredient?: Tranexamic acid.
Who is the labeler?: AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tranexamic Acid?: 43 other product NDCs are listed under this name. See all Tranexamic Acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tranexamic Acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	NorthStar Rx LLC	72603-818	72603-0818-01
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	i3 Pharmaceuticals, LLC	72319-028	72319-0028-01
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	Dr. Reddy's Laboratories Inc.	75907-309	75907-0309-30
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-106	65145-0106-10
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-909	23155-0909-41
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-910	23155-0910-41
Tranexamic Acid	Tranexamic acid 100 mg/mL	InjectionIntravenous	Northstar Rx LLC	72603-387	72603-0387-10
Tranexamic Acid	Tranexamic acid 1 g/10mL	Injection, SolutionIntravenous	Emcure Pharmaceuticals Limited	14593-318	14593-0318-01
Tranexamic Acid	Tranexamic acid 10 mg/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-418	25021-0418-82
Tranexamic Acid	Tranexamic acid 10 mg/mL	Injection, SolutionIntravenous	Nexus Pharmaceuticals LLC	14789-115	14789-0115-05

All 44 Tranexamic Acid NDCs

Other NDCs under NDA 022430

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022430
Product	Strength	Form · route	Labeler	Product NDC
Tranexamic Acid	Tranexamic acid 650 mg/1	TabletOral	Nordic Pharma, Inc.	69918-301